Involvement of GABA in the actions of neuropsychotropic drugs.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology; D001569:Benzodiazepines; D002415:Cats; D002525:Cerebellar Cortex / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D006624:Hippocampus / Q000187:drug effects; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D009118:Muscimol / Q000494:pharmacology; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D011619:Psychotropic Drugs / Q000494:pharmacology*; D011689:Purkinje Cells / Q000187:drug effects; D051381:Rats; D013116:Spinal Cord / Q000187:drug effects; D013378:Substantia Nigra / Q000187:drug effects; D003689:Vestibular Nucleus, Lateral / Q000187:drug effects; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D001463:Barbiturates; D006993:Hypnotics and Sedatives; D009125:Muscle Relaxants, Central; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D009118:Muscimol; D005680:gamma-Aminobutyric Acid